Kurt R. Oettel

Characteristics and outcome of patients with active pulmonary tuberculosis requiring intensive care

R Erbes, Kurt R. Oettel, M. Raffenberg et al. · European Respiratory Journal · 2006 · 125 citations · Full text

Pulmonary Care, Tuberculosis Prevention, Active Pulmonary Tuberculosis +16

American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care

Nathan A. Pennell, Melissa S. Dillmon, Laura A. Levit et al. · Journal of Clinical Oncology · 2020 · 84 citations · Full text

Nursing, Cancer Care Delivery, Health Policy +14

Cetuximab plus carboplatin and paclitaxel with or without bevacizumab versus carboplatin and paclitaxel with or without bevacizumab in advanced NSCLC (SWOG S0819): a randomised, phase 3 study

Roy S. Herbst, Mary W. Redman, Edward S. Kim et al. · The Lancet Oncology · 2017 · 74 citations · Full text

Advanced Nsclc, Swog S0819, Oncology +8

MHC-unrestricted cytotoxic and proliferative responses of two distinct human γ/δ T cell subsets to Daudi cells

Paul Fisch, Kurt R. Oettel, N Fudim et al. · The Journal of Immunology · 1992 · 71 citations

Phase I trial of 1alpha-hydroxyvitamin d(2) in patients with hormone refractory prostate cancer.

Glenn Liu, Kurt R. Oettel, Gregory H. Ripple et al. · PubMed · 2002 · 65 citations

Urology, Genitourinary Cancer, Medicine +9